Business Standard

1 drug sample spurious and nearly 48 substandard in June inspection

Eye-drops made by Indiana Ophthalmics in Gujarat that have been under the scanner also feature in the list

pharma, medicine, drugs
Premium

The Schedule M of the Drugs and Cosmetics Act 1940 deals with good manufacturing practices for pharma manufacturing units in India.

Sohini Das Mumbai

Listen to This Article

Around 48 of the 1,273 drug samples tested for quality in June were found to be of non-standard quality (NSQ). Samples from two public-sector pharmaceutical firms also featured in the list, as did some of the reputed pharma firms.

According to a document seen by Business Standard, 1,273 drug samples were tested by government laboratories across the country in June. Of them, 1,225 samples were declared of standard quality. One sample was found to be spurious and 48 were of non-standard quality.

The Central Drugs Standard Control Organisation (CDSCO) runs the exercise regularly. State drug inspectors pick up random samples

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 24 2023 | 9:49 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com